| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ultragenyx Pharmaceutical Inc. (RARE) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. RARE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 132.7K | $3.47M | - | |
| CFO | 88.9K | $2.32M | - | |
| Other | 79.9K | $2.09M | - | |
| Other | 79.9K | $2.09M | - | |
| VP | 50.5K | $1.32M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2025 | Horn Howard80 | Chief Financial Officer | Sell | 1,785 | $40.40 | $72,114.00 | -1.7% | -8.5% | -46.9% | |
| Mar 3, 2025 | Harris Erik75 | EVP &Chief Commercial Officer | Sell | 15,103 | $42.10 | $635,836.30 | -14.7% | -12.4% | -46.5% | |
| Mar 3, 2025 | Kassberg Thomas Richard68 | Cbo &EVP | Sell | 6,028 | $42.10 | $253,778.80 | -2.2% | -12.4% | -46.5% | |
| Mar 3, 2025 | Parschauer Karah Herdman77 | EVP And Chief Legal Officer | Sell | 12,846 | $42.10 | $540,816.60 | -14.6% | -12.4% | -46.5% | |
| Mar 3, 2025 | Crombez Eric74 | EVP And Chief Medical Officer | Sell | 8,945 | $42.10 | $376,584.50 | -11.1% | -12.4% | -46.5% | |
| Mar 3, 2025 | Pinion John Richard73 | See Remarks | Sell | 14,439 | $42.10 | $607,881.90 | -11.8% | -12.4% | -46.5% | |
| Mar 3, 2025 | Huizenga Theodore Alan65 | SVP, Chief Accounting Officer | Sell | 967 | $42.10 | $40,710.70 | -1.9% | -12.4% | -46.5% | |
| Mar 3, 2025 | Kakkis Emil D72 | President &CEO | Sell | 98,434 | $42.20 | $4,153,571.40 | -3.4% | -12.4% | -46.5% | |
| Feb 27, 2025 | Parschauer Karah Herdman77 | EVP And Chief Legal Officer | Sell | 2,990 | $42.88 | $128,223.90 | -2.6% | -18.2% | -44.3% | |
| Dec 30, 2024 | Kakkis Emil D72 | President &CEO | Sell | 11,727 | $42.23 | $495,231.21 | -0.5% | -14.3% | -46.1% |